{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:37:18Z","timestamp":1790660238388,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,15]]},"DOI":"10.1097\/tp.0b013e3181de1d67","type":"journal-article","created":{"date-parts":[[2010,5,30]],"date-time":"2010-05-30T13:26:24Z","timestamp":1275225984000},"page":"31-37","source":"Crossref","is-referenced-by-count":36,"title":["Optimal Everolimus Concentration Is Associated With Risk Reduction for Acute Rejection in De Novo Renal Transplant Recipients"],"prefix":"10.1097","volume":"90","author":[{"given":"Laurence","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Cibrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.TP.0000141094.34903.54","article-title":"Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients.","volume":"78","author":"V\u00edtko","year":"2004","journal-title":"Transplantation"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1600-6143.2005.01063.x","article-title":"Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients.","volume":"5","author":"V\u00edtko","year":"2005","journal-title":"Am J Transplant"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000164352.65613.24","article-title":"Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: A 3-year randomized, multicenter, phase III study.","volume":"80","author":"Lorber","year":"2005","journal-title":"Transplantation"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-0012.2005.00326.x","article-title":"Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data.","volume":"19","author":"Lorber","year":"2005","journal-title":"Clin Transplant"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/01.TP.0000140486.97461.49","article-title":"Everolimus and reduced- exposure cyclosporine in de novo renal-transplant recipients: A three-year phase II, randomized, multicenter, open-label study.","volume":"78","author":"Nashan","year":"2004","journal-title":"Transplantation"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2004.00389.x","article-title":"Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-Month safety and efficacy results of two randomized studies.","volume":"4","author":"V\u00edtko","year":"2004","journal-title":"Am J Transplant"},{"issue":"Suppl 11","key":"R7-6-20210129","first-page":"A1010","article-title":"Excellent graft function in de novo kidney transplant recipients treated with Certican, Simulect and reduced Neoral exposure: 24 month results.","volume":"5","author":"Leone","year":"2005","journal-title":"Am J Transplant"},{"issue":"Suppl 11","key":"R8-6-20210129","first-page":"A1010","article-title":"Efficacy and safety of 2 doses of everolimus combined with reduced dose Neoral in de novo kidney transplant recipients: 24 Months analysis.","volume":"5","author":"Pascual","year":"2005","journal-title":"Am J Transplant"},{"issue":"Suppl 8","key":"R9-6-20210129","first-page":"296","article-title":"Efficacy and safety of 2 doses of everolimus combined with reduced-dose Neoral in de novo kidney transplant recipients: 12 Month analysis [abstract 504].","volume":"4","author":"Magee","year":"2004","journal-title":"Am J Transplant"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00007890-200203270-00016","article-title":"Exposure-response relationships for everolimus in de novo kidney transplantation: Defining a therapeutic range.","volume":"73","author":"Kovarik","year":"2002","journal-title":"Transplantation"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007691-200410000-00007","article-title":"Everolimus therapeutic concentration range defined from a prospective trial with reduced-exposure cyclosporine in de novo kidney transplantation.","volume":"26","author":"Kovarik","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/TP.0b013e318166927b","article-title":"Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.","volume":"85","author":"Chan","year":"2008","journal-title":"Transplantation"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0091270002042001011","article-title":"Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: A clinically relevant pharmacokinetic interaction.","volume":"42","author":"Kovarik","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1034\/j.1600-6143.2003.00107.x","article-title":"Pharmacokinetics of an everolimus-cyclosporine immunosuppressive regimen over the first 6 months after kidney transplantation.","volume":"3","author":"Kovarik","year":"2003","journal-title":"Am J Transplant"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0091270005277196","article-title":"Influence of everolimus on steady-state pharmacokinetics of cyclosporine in maintenance renal transplant patients.","volume":"45","author":"Budde","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-199802270-00011","article-title":"Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 kidney transplant study group.","volume":"65","author":"Neylan","year":"1998","journal-title":"Transplantation"},{"key":"R18-6-20210129","first-page":"379","article-title":"The effect of race and ethnicity on kidney allograft outcome.","author":"Katznelson","year":"1995","journal-title":"Clin Transpl"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.transproceed.2006.10.092","article-title":"Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.","volume":"38","author":"Kovarik","year":"2006","journal-title":"Tranplant Proc"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/FTD.0b013e318161a335","article-title":"Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.","volume":"30","author":"Brandhorst","year":"2008","journal-title":"Ther Drug Monit"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201007150-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:25:59Z","timestamp":1786040759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201007150-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181de1d67","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7,15]]}}}